David Veitch
Patrimonio netto: 2 M $ in data 30/06/2026
Patrimonio netto: 2 M $ in data 30/06/2026
David Veitch is Chief Executive Officer at Basilea Pharmaceutica AG since 2018, with employment at the firm starting in 2014.
Formerly, Mr. Veitch was President-European Operations at Savient Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, Mr. Veitch was SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2007 to 2011.
Education includes an undergraduate degree from the University of Bristol.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 25.660 ( 0,19% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Amministratore Delegato | 19/04/2018 |
| Società | Posizione | Fine |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale